Footnotes

Chapter 1 - Introduction

[1]        Journals of the Senate, No. 132, 7 February 2013, p. 3596.

Chapter 2

[1]        Department of Health and Ageing, Portfolio Budget Statements 2012-13, Outcome 2.2, p. 90.

[2]        The Department of Human Services, Explanation of PBS Pricing, http://www.medicareaustralia.gov.au/provider/pbs/pharmacists/pricing.jsp#N1021C (Accessed 3 April 2013).  The Department of Human Services also notes that, "The Pharmaceutical Benefits Remuneration Tribunal ... implements agreements between the Minister for Health and Ageing ... and the Pharmacy Guild of Australia, as to how the PBS dispensed price is to be established (Section 98BAA of the Act)."

[3]        Department of Health and Ageing, The Impact of PBS Reform – Report to Parliament on the National Health Amendment (Pharmaceutical Benefits Scheme) Act 2007, 2010, p. 20.

[4]        Department of Health and Ageing, Pharmacy and Government Arrangements - Fifth Community Pharmacy Agreement, 25 July 2012, http://www.health.gov.au/internet/main/publishing.nsf/Content/fifth-community-pharmacy-agreement-copy (Accessed 1 May 2013).

[5]        The Pharmacy Guild of Australia, The 5CPA – History of the Agreements, http://www.5cpa.com.au/sites/5CPA/The_5CPA/History_of_the_Agreements/History%20of%20the%20Agreements.page (Accessed 1 May 2013).

[6]        Commonwealth Government & the Pharmacy Guild of Australia, The Fifth Community Pharmacy Agreement between the Commonwealth of Australia and the Pharmacy Guild of Australia, May 2010, cl. 7. 

[7]        Commonwealth Government & Medicines Australia, Memorandum of Understanding, 6 May 2010, http://www.health.gov.au/internet/main/publishing.nsf/Content/further-PBS-reforms-Agreement (Accessed 3 April 2013).

[8]        See, the Department of Health and Ageing, Revised Arrangements for the Efficient Funding of Chemotherapy Drugs & Streamlined Authority Data Capture, http://www.pbs.gov.au/info/‌publication/factsheets/shared/revised-arrangements-for-chemotherapy; and Department of Health and Ageing, Pharmacy and Government Arrangements - Fifth Community Pharmacy Agreement,  http://www.health.gov.au/internet/main/publishing.nsf/Content/fifth-community-pharmacy-agreement (Accessed 8 April 2013).

[9]        Community Pharmacy Chemotherapy Services Group, Submission 20, p. 1, and Submission 20a; the Department of Health and Ageing, Submission 35, p. 5.

[10]      Pharmacy Guild of Australia, Submission 25, p. 20.

Chapter 3 - Chemotherapy funding

[1]        UnitingCare Health, Submission 26, p 2.

[2]        Mr Tony Noun, Executive Chairman Northern Cancer Institute, Committee Hansard, 28 March 2013, pp. 8–9.

[3]        Dr Brett Robinson, Chief Executive Officer Integrated Clinical Oncology Network, Committee Hansard, 28 March 2013, p. 44.

[4]        Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 5, and Integrated Clinical Oncology Network, Submission 19, p. 9.

[5]        Dr Brett Robinson, Chief Executive Officer Integrated Clinical Oncology Network, Committee Hansard, 28 March 2013, p. 45.

[6]        Augusta Road Capital Chemist, Submission 29, p. 1.

[7]        The Pharmacy Guild of Australia, Submission 25, p. 32.

[8]        APHS Pharmacy Group, Submission 31, p. 7.

[9]        Department of Health and Ageing, Submission 35, p. 13.

[10]      See Pharmacy Guild of Australia, Submission 25, pp. 4, 14; Community Pharmacy Chemotherapy Services Group, Submission 20, p. 2.

[11]      Department of Health and Ageing, Submission 35, p. 14.

[12]      Department of Health and Ageing, Submission 35, p. 5.

[13]      The Pharmacy Guild of Australia, Pharmacy Guild 2010 Budget Brief, 11 May 2010, http://beta.guild.org.au/uploadedfiles/National/Public/Media_Centre/budget_11May2010.pdf (Accessed 17 April 2013).  

[14]      Mr David Learmonth, Deputy Secretary Department of Health and Ageing, Committee Hansard, 28 March 2013, p. 31.

[15]      Department of Health and Ageing, Submission 35, p. 5.

[16]      The Pharmacy Guild of Australia, Submission 25, pp. 16–17.

[17]      Department of Health and Ageing, Overview of the Fifth Community Pharmacy Agreement, p. 4 of 7, http://www.health.gov.au/internet/main/publishing.nsf/Content/C3DB799DB360AF0CCA‌25772000249FA8/$File/5CPA fact sheet.pdf (Accessed 17 April 2013).

[18]      Department of Health and Ageing, Portfolio Budget Statements 2010-11, p. 111.

[19]      Mr Armstrong, The Pharmacy Guild of Australia, evidence to Senate Community Affairs Legislation Committee, Inquiry into the National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2010: Official Committee Hansard, 9 November 2010, p. 13.

[20]      Mr Armstrong, The Pharmacy Guild of Australia, evidence to Senate Community Affairs Legislation Committee, Inquiry into the National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2010: Official Committee Hansard, 9 November 2010, p. 16.

[21]      Pharmacy Guild of Australia, Submission 25, pp. 16–17; Submission 25ss, 2–6.

[22]      The Hon Nicola Roxon MP, Minister for Health and Ageing, 'Agreements Ensure Sustainable Access to Medicines', Media Release, 11 May 2010, http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr10-nr-nr094.htm?OpenDocument&yr=2010&mth=05 (Accessed 15 April 2013).

[23]      Department of Health and Ageing, Portfolio Budget Statements 2010–11, p. 111.

[24]      Pharmacy Guild of Australia, Submission 25, pp. 17.

[25]      National Health Act (Pharmaceutical Benefits Scheme) Amendment Bill 2010, Explanatory Memorandum, p. 2.

[26]      National Health Act (Pharmaceutical Benefits Scheme) Amendment Bill 2010, Explanatory Memorandum p. 3.

[27]      National Health Act (Pharmaceutical Benefits Scheme) Amendment Bill 2010, Explanatory Memorandum, p. 3.

[28]      The Pharmacy Guild of Australia, Submission 25ss, pp. 3 and 5.

[29]      The Department of Health and Ageing, Letter to Dr Ian Holland, Secretary Senate Community Affairs Committee, 29 April 2013.

[30]      The Department of Health and Ageing, Letter to Dr Ian Holland, Secretary Senate Community Affairs Committee, 29 April 2013.

[31]      The Pharmacy Guild of Australia, Pharmacy Guild 2010 Budget Brief, 11 May 2010, p. 4 of 7,  http://beta.guild.org.au/uploadedfiles/National/Public/Media_Centre/budget_11May2010.pdf (Accessed 17 April 2013).

[32]      Department of Health and Ageing, Pharmacy, PBS Chemotherapy Medicines Review, http://www.health.gov.au/chemo-review (Accessed 7 May 2013).

[33]      The Hon Tanya Plibersek, 'Review to determine correct subsidy for chemotherapy infusions', Media Release, 5 May 2013.

Coalition Senators' Additional comments

[1]        Medical Oncology Group of Australia Inc. and Private Cancer Physicians of Australia, Submission 17, p. 2.

[2]        Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 3.

[3]        Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 3.

[4]        The Pharmacy Guild of Australia, Submission 25, p. 4.

[5]        Sydney Adventist Hospital, Adventist Healthcare, Submission 15, p. 2.

[6]        Slade Pharmacy Services, Submission 9, p. 2.

[7]        Medical Oncology Group of Australia Inc. and Private Cancer Physicians of Australia, Submission 17, p. 4.

[8]        Hon Tanya Plibersek MP, Minister for Health, 'Review to Determine Correct Subsidy for Chemotherapy Infusions', Media Release, 5 May 2013.

[9]        Committee Hansard, 28 March 2013, p. 6.

[10]      Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 7.

[11]      Cabrini, Submission 3, p. 3.

[12]      Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 5.

[13]      Medical Oncology Group of Australia Inc. and Private Cancer Physicians of Australia, Submission 17, p. 5.

[14]      Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 5.

[15]      Clinical Oncological Society of Australia and Cancer Pharmacists Group, Submission 16, p. 7.

[16]      Committee Hansard, 28 March 2013, p. 4.

[17]      Dr Christopher Steer, ‘A regional perspective’, tabled by APHS Pharmacy Group, 28 March 2013.

Additional comments by Senator Nick Xenophon

[1]        Mr Dan Mellor, Committee Hansard, 28 March 2013, p. 7.

[2]        Mr Wayne Pertzel, Committee Hansard, 28 March 2013, p. 22.

[3]        Mr Wayne Pertzel, Committee Hansard, 28 March 2013, p. 23

[4]        Mr Noun, Committee Hansard, 28 March 2013, p. 16.

[5]        Name Withheld, Submission 30, p. 5.

[6]        Name Withheld, Submission 30, p. 5

[7]        Ms Carol Bennett, Committee Hansard, 28 March 2013, p. 37.

[8]        Dr John Bashford and Dr Leon Clark, Committee Hansard, 28 March 2013, p. 46.

[9]        Dr Leon Clark, Committee Hansard, 28 March 2013, p. 47.